Methylphenidate
Cross-source consensus on Methylphenidate from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Benefits
Risks & contraindications
Other
Highlighted claims
- All META trial participants receive methylphenidate after ADHD diagnosis and dose titration. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
- Methylphenidate response varies between patients and may be limited by side effects or early discontinuation. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
- Methylphenidate efficacy for adult ADHD is well documented in the article. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
- Methylphenidate tolerance is monitored through functional signs, weight, pulse and blood pressure at follow-up visits. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol
- Methylphenidate has no curative or residual effect after treatment discontinuation according to the article. — Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction – META study protocol